Dupilumab‐associated head and neck dermatitis is associated with elevated pretreatment serum Malassezia‐specific IgE: a multicentre, prospective cohort study

Dupilumab associated head and neck dermatitis is incompletely understood. This prospective multicentre prospective study identified baseline Malassezia‐specific IgE as associated with the development of Dupilumab associated head and neck dermatitis.[Image: see text]

Detalles Bibliográficos
Autores principales: Kozera, Emily, Stewart, Thomas, Gill, Kyra, De La Vega, Mae Anne, Frew, John W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322676/
https://www.ncbi.nlm.nih.gov/pubmed/35041759
http://dx.doi.org/10.1111/bjd.21019
_version_ 1784756363635720192
author Kozera, Emily
Stewart, Thomas
Gill, Kyra
De La Vega, Mae Anne
Frew, John W.
author_facet Kozera, Emily
Stewart, Thomas
Gill, Kyra
De La Vega, Mae Anne
Frew, John W.
author_sort Kozera, Emily
collection PubMed
description Dupilumab associated head and neck dermatitis is incompletely understood. This prospective multicentre prospective study identified baseline Malassezia‐specific IgE as associated with the development of Dupilumab associated head and neck dermatitis.[Image: see text]
format Online
Article
Text
id pubmed-9322676
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-93226762022-07-30 Dupilumab‐associated head and neck dermatitis is associated with elevated pretreatment serum Malassezia‐specific IgE: a multicentre, prospective cohort study Kozera, Emily Stewart, Thomas Gill, Kyra De La Vega, Mae Anne Frew, John W. Br J Dermatol Correspondence Dupilumab associated head and neck dermatitis is incompletely understood. This prospective multicentre prospective study identified baseline Malassezia‐specific IgE as associated with the development of Dupilumab associated head and neck dermatitis.[Image: see text] John Wiley and Sons Inc. 2022-04-19 2022-06 /pmc/articles/PMC9322676/ /pubmed/35041759 http://dx.doi.org/10.1111/bjd.21019 Text en © 2022 The Authors. British Journal of Dermatology published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Correspondence
Kozera, Emily
Stewart, Thomas
Gill, Kyra
De La Vega, Mae Anne
Frew, John W.
Dupilumab‐associated head and neck dermatitis is associated with elevated pretreatment serum Malassezia‐specific IgE: a multicentre, prospective cohort study
title Dupilumab‐associated head and neck dermatitis is associated with elevated pretreatment serum Malassezia‐specific IgE: a multicentre, prospective cohort study
title_full Dupilumab‐associated head and neck dermatitis is associated with elevated pretreatment serum Malassezia‐specific IgE: a multicentre, prospective cohort study
title_fullStr Dupilumab‐associated head and neck dermatitis is associated with elevated pretreatment serum Malassezia‐specific IgE: a multicentre, prospective cohort study
title_full_unstemmed Dupilumab‐associated head and neck dermatitis is associated with elevated pretreatment serum Malassezia‐specific IgE: a multicentre, prospective cohort study
title_short Dupilumab‐associated head and neck dermatitis is associated with elevated pretreatment serum Malassezia‐specific IgE: a multicentre, prospective cohort study
title_sort dupilumab‐associated head and neck dermatitis is associated with elevated pretreatment serum malassezia‐specific ige: a multicentre, prospective cohort study
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322676/
https://www.ncbi.nlm.nih.gov/pubmed/35041759
http://dx.doi.org/10.1111/bjd.21019
work_keys_str_mv AT kozeraemily dupilumabassociatedheadandneckdermatitisisassociatedwithelevatedpretreatmentserummalasseziaspecificigeamulticentreprospectivecohortstudy
AT stewartthomas dupilumabassociatedheadandneckdermatitisisassociatedwithelevatedpretreatmentserummalasseziaspecificigeamulticentreprospectivecohortstudy
AT gillkyra dupilumabassociatedheadandneckdermatitisisassociatedwithelevatedpretreatmentserummalasseziaspecificigeamulticentreprospectivecohortstudy
AT delavegamaeanne dupilumabassociatedheadandneckdermatitisisassociatedwithelevatedpretreatmentserummalasseziaspecificigeamulticentreprospectivecohortstudy
AT frewjohnw dupilumabassociatedheadandneckdermatitisisassociatedwithelevatedpretreatmentserummalasseziaspecificigeamulticentreprospectivecohortstudy

Ejemplares similares